Stubbs VC, et al. - Using the National Cancer Database (NCDB), researchers determined the impact of payer status on survival in parotid malignancy. For this retrospective database review, 15,815 cases were included and the majority had private insurance, followed by Medicare, Medicaid, uninsured and other government sources. Uninsured, Medicaid, and Medicare patients have worse survival results vs those with private insurance in parotid malignancy. Uninsured and Medicaid patients also have more advanced stage disease and increased waiting times before the initiation of definitive therapy.